Familial aspect of primary hyperaldostéronism: Analysis of families compatible with primary hyperaldosteronism type 2;Aspect familial de l'hyperaldostéronisme primaire: Analyse de familles compatibles avec un hyperaldostéronisme primaire de type 2

Annales d'Endocrinologie

Volumn 66, Issue 3, 2005, Pages 240-246

  Medeau V ^a,b,c   Assie G ^d   Zennaro, M Chr ^a,b,c   Clauser, E ^d   Plouin, P Fr ^a,b,c   Jeunemaitre, X ^a,b,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c l'alimentation et l'Environnement   (France)

^d INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; AUTOSOMAL DOMINANT INHERITANCE; CONFERENCE PAPER; FAMILIAL DISEASE; FAMILY HISTORY; GENEALOGY; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; PHENOTYPE; PRIMARY HYPERALDOSTERONISM; SIGNAL TRANSDUCTION;

EID: 18944364034     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(05)81756-1     Document Type: Conference Paper

References (22)

1. Bossis I, Voutetakis A, Bei T, Sandrini F, Griffin KJ, Stratakis CA. Protein kinase A and its role in human neoplasia: the Carney complex paradigm. Endocr Relat Cancer 2004 ; 11 : 265-80.
2. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002 ; 40 : 892-6
3. Conn JW. Primary aldosteronism, a new clinical syndrome. Journal of Laboratory and Clinical Medecine. 1955 ; 45 : 3-17.
4. Gates LJ, MacConnachie AA, Lifton RP, Haites NE, Benjamin N. Variation of phenotype in patients with glucocorticoid remediable aldosteronism. J Med Genet 1996 ; 33 : 25-8.
5. Goncharuk VN, Ross JS, Carlson JA. Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 2002 ; 29 : 430-8.
6. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994 ; 21 : 315-8.
7. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. Primary aldosteronism- some genetic, morphological and biochemical aspects of subtypes. Steroids 1995 ; 60 : 35-41.
8. Greco RG, Carroll JE, Morris DJ, et al. Familial hyperaldosteronism, not suppressed by dexamethasone. J Clin Endocrinol Metab 1982 ; 55 : 1013-6.
9. Kaplan NM. Cuations over the current epidemic of primary aldosteronism. Lancet 2001 ; 357 : 953-4.
10. Khan IU, Laxminarayana D, Kammer GM. Protein kinase A RI beta subunit deficiency in lupus T lymphocytes: bypassing a block in RI beta translation reconstitutes protein kinase A activity and augments IL-2 production. J Immunol 2001 ; 166 : 7600-5.
11. Kureishy N, Sapountzi V, Prag S, et al. Fascins, and their roles in cell structure and function. Bioessays 2002 ; 24 : 350-61.
12. Lafferty AR, Torpy DJ, Stowasser M, et al. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7. J Med Genet 2000 ; 37 : 831-5.
13. Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11β-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature, 1992, 355 : 262-5.
14. Pascoe L, Jeunemaitre X, Lebrethon MC, et al. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest. 1995 ; 96 : 2236-46.
15. Plouin PF, Amar L, Chatellier G. Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrol Dial Transplant 2004 ; 19 : 774-7.
16. Solberg R, Tasken K, Keiserud A, et al. Molecular cloning, cDNA structure and tissue-specific expression of the human regulatory subunit RI beta of cAMP-dependent protein kinases. Biochem Biophys Res Commun 1991 ; 176 : 166-72.
17. Stowasser M, Gordon RD, Tunny TJ, et al. Familial hyperaldosteronism type II : five families with a new variety of primary aldosteronism. Clin Exp Pharmacol Physiol 1992 ; 19 : 319-22.
18. Stowasser M, Gordon RD. Familial hyperaldosteronism. J Steroid Biochem 2001 ; 78: 215-29.
19. Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 1966 ; 95 : 1109-19.
20. Tasken K, Skalhegg BS, Tasken KA, et al. Structure, function, and regulation of human cAMP-dependent protein kinases. Adv Second Messenger Phosphoprotein Res. 1997 ; 31 : 191-204. Review.
21. Yamashiro S, Yamakita Y, Ono S, et al. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell. 1998 ; 9 : 993-1006.
22. Young WF, Hogan MJ, Klee GG, et al. Primary aldosteronism : diagnosis and treatment. Mayo Clin Proc 1990 ; 65 : 96-110.